Based on the 2025 Franchise Disclosure Document, it is not possible to determine how often Anago reviews its investments for impairment. While the document includes financial statements and notes, it does not explicitly state the frequency or process by which Anago reviews its investments for potential impairment. The notes to the consolidated financial statements do discuss risk and customer concentrations. Also, subsequent events have been evaluated through March 17, 2025, which is the date the consolidated financial statements were available to be issued.

Without a clear statement on impairment review frequency, prospective franchisees should directly ask Anago's management about their policies and procedures for assessing the value of their investments. Understanding how frequently Anago conducts these reviews, and the criteria they use, can provide valuable insight into the company's financial management practices and risk assessment.

To gain a comprehensive understanding, potential franchisees should inquire about the specific triggers that would prompt an impairment review, the methods used to determine impairment, and the historical frequency of such reviews. This information will help them evaluate the financial stability and risk management practices of Anago.